Bacteriophages ϕMR299-2 and ϕNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells
Open Access
- 2 May 2012
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 3 (2), e00029-12-12
- https://doi.org/10.1128/mbio.00029-12
Abstract
Pseudomonas aeruginosa is a common cause of infection in the lungs of patients with cystic fibrosis (CF). In addition, biofilm formation and antibiotic resistance of Pseudomonas are major problems that can complicate antibiotic therapy. We evaluated the efficacy of using bacteriophages to kill the pathogen in both biofilms and in the murine lung. We isolated and characterized two phages from a local wastewater treatment plant, a myovirus (ϕNH-4) and a podovirus (ϕMR299-2). Both phages were active against clinical isolates of P. aeruginosa . Together, the two phages killed all 9 clinical isolate strains tested, including both mucoid and nonmucoid strains. An equal mixture of the two phages was effective in killing P. aeruginosa NH57388A (mucoid) and P. aeruginosa MR299 (nonmucoid) strains when growing as a biofilm on a cystic fibrosis bronchial epithelial CFBE41o- cell line. Phage titers increased almost 100-fold over a 24-h period, confirming replication of the phage. Furthermore, the phage mix was also effective in killing the pathogen in murine lungs containing 1 × 10 7 to 2 × 10 7 P. aeruginosa . Pseudomonas was effectively cleared (reduced by a magnitude of at least 3 to 4 log units) from murine lungs in 6 h. Our study demonstrates the efficacy of these two phages in killing clinical Pseudomonas isolates in the murine lung or as a biofilm on a pulmonary cell line and supports the growing interest in using phage therapy for the control and treatment of multidrug-resistant Pseudomonas lung infections in CF patients. IMPORTANCE Given the rise in antibiotic resistance, nonantibiotic therapies are required for the treatment of infection. This is particularly true for the treatment of Pseudomonas infection in patients with cystic fibrosis. We have identified two bacterial viruses (bacteriophages) that can kill Pseudomonas growing on human lung cells and in an animal model of lung infection. The use of bacteriophages is particularly appropriate because the killing agent can replicate on the target cell, generating fresh copies of the bacteriophage. Thus, in the presence of a target, the killing agent multiplies. By using two bacteriophages we can reduce the risk of resistant colonies developing at the site of infection. Bacteriophage therapy is an exciting field, and this study represents an important demonstration of efficacy in validated infection models.Keywords
This publication has 65 references indexed in Scilit:
- Efficacy of Bacteriophage Therapy in a Model ofBurkholderia cenocepaciaPulmonary InfectionThe Journal of Infectious Diseases, 2010
- Bacteriophage Cocktail for the Prevention of Biofilm Formation by Pseudomonas aeruginosa on Catheters in an In Vitro Model SystemAntimicrobial Agents and Chemotherapy, 2010
- Experimental Bacteriophage Therapy Increases Survival of Galleria mellonella Larvae Infected with Clinically Relevant Strains of the Burkholderia cepacia ComplexAntimicrobial Agents and Chemotherapy, 2009
- Artemis and ACT: viewing, annotating and comparing sequences stored in a relational databaseBioinformatics, 2008
- In Vitro Analysis of Tobramycin-Treated Pseudomonas aeruginosa Biofilms on Cystic Fibrosis-Derived Airway Epithelial CellsInfection and Immunity, 2008
- Construction of p16S lux , a Novel Vector for Improved Bioluminescent Labeling of Gram-Negative BacteriaApplied and Environmental Microbiology, 2007
- Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptidesJournal of Applied Microbiology, 2007
- Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patientsJCI Insight, 2002
- Improved microbial gene identification with GLIMMERNucleic Acids Research, 1999
- Basic Local Alignment Search ToolJournal of Molecular Biology, 1990